Felicitas Hitz

6PUBLICATIONS
31CO-AUTHORS
Rheumatology and arthritisMedical genetics (excl. cancer genetics)Predictive and prognostic markersSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
SAKK 35/14 randomized trial of rituximab with or without ibrutinib for patients with untreated follicular lymphoma.

|Dec 07, 2023
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.

Jakob R Passweg, Helen Baldomero, Marc Ansari

|May 16, 2022
Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life setting.

Murielle Lalive d'Epinay, Sabine Güsewell, Nicole Graf

|Sep 28, 2021
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods.

Felicitas Hitz, Karin Ribi, Gudela Grote

|May 19, 2019
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi

Pageof 1

Frequent Collaborators

2 joint publications

Emanuele Zucca

2 joint publications

Urban Novak

2 joint publications

Thilo Zander

2 joint publications

Fatime Krasniqi